mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-09 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-08 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-06 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |